Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
43
Top-10 weight
57.43%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
22
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1332.7
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 171,340 | $180.25M | 11.34% |
| 2 | JOHNSON&JOHNSON | — | 569,943 | $141.59M | 8.91% |
| 3 | ABBVIE INC | — | 406,900 | $94.43M | 5.94% |
| 4 | Novartis AG (Registered) | NVSEF | 522,868 | $87.92M | 5.53% |
| 5 | MERCK & CO | — | 684,671 | $84.78M | 5.33% |
| 6 | ASTRAZENECA PLC | — | 381,146 | $80.21M | 5.04% |
| 7 | UNITEDHEALTH GRP | — | 266,960 | $78.29M | 4.92% |
| 8 | INTUITIVE SURGICAL INC | — | 123,020 | $61.94M | 3.90% |
| 9 | THERMO FISHER SCIENTIFIC INC | — | 112,920 | $58.84M | 3.70% |
| 10 | ROCHE HOLDINGS AG (GENUSSCHEINE) | — | 97,154 | $46.24M | 2.91% |
| 11 | BOSTON SCIENTIFIC CORP | — | 587,248 | $45.13M | 2.84% |
| 12 | GILEAD SCIENCES INC | — | 286,000 | $42.60M | 2.68% |
| 13 | MCKESSON CORP | — | 42,240 | $41.71M | 2.62% |
| 14 | MEDTRONIC PLC | — | 402,600 | $39.32M | 2.47% |
| 15 | Sanofi SA | — | 379,940 | $37.16M | 2.34% |
| 16 | VERTEX PHARMACEUTICALS INC | — | 73,860 | $36.70M | 2.31% |
| 17 | CARDINAL HEALTH INC | — | 157,400 | $36.08M | 2.27% |
| 18 | BRISTOL-MYERS SQUIBB CO | — | 530,200 | $33.07M | 2.08% |
| 19 | CVS HEALTH CORP | — | 366,300 | $29.27M | 1.84% |
| 20 | Ascendis Pharma A/S | — | 113,788 | $26.57M | 1.67% |
| 21 | EDWARDS LIFESCIENCES CORP | — | 298,500 | $25.81M | 1.62% |
| 22 | HCA HEALTHCARE INC | — | 45,780 | $24.25M | 1.53% |
| 23 | NOVO NORDISK-B | — | 610,832 | $23.10M | 1.45% |
| 24 | Putnam Short Term Investment Fund, Class P | — | 21,062,165 | $21.06M | 1.32% |
| 25 | ALNYLAM PHARMACEUTICALS INC | — | 62,800 | $20.91M | 1.32% |
| 26 | CHUGAI PHARMA CO | — | 296,300 | $19.98M | 1.26% |
| 27 | HOYA CORP | — | 109,700 | $19.81M | 1.25% |
| 28 | REGENERON PHARMACEUTICALS INC | — | 25,018 | $19.56M | 1.23% |
| 29 | UCB SA | — | 54,918 | $16.50M | 1.04% |
| 30 | ARGENX SE | — | 20,864 | $16.14M | 1.02% |
| 31 | ABBOTT LABS | — | 135,900 | $15.81M | 0.99% |
| 32 | BECTON DICKINSON and CO | — | 88,700 | $15.65M | 0.98% |
| 33 | GSK PLC | — | 509,032 | $15.13M | 0.95% |
| 34 | VAXCYTE INC | — | 228,000 | $14.08M | 0.89% |
| 35 | INSMED INC | — | 89,900 | $13.42M | 0.84% |
| 36 | RHYTHM PHARMACEUTICALS INC | — | 107,800 | $10.00M | 0.63% |
| 37 | NEWAMSTERDAM PHARMA COMPANY NV | — | 113,900 | $4.04M | 0.25% |
| 38 | PRECIGEN INC | — | 910,700 | $3.45M | 0.22% |
| 39 | Putnam Cash Collateral Pool LLC | — | 2,403,534 | $2.40M | 0.15% |
| 40 | U.S. Treasury Bills | — | 1,900,000 | $1.87M | 0.12% |
| 41 | US ULTRA BOND CBT Sep25 | — | 43,285,080 | $1.66M | 0.10% |
| 42 | US ULTRA BOND CBT Sep25 | — | 1 | $1.09M | 0.07% |
| 43 | US ULTRA BOND CBT Sep25 | — | 1 | $991.20K | 0.06% |
| 44 | US ULTRA BOND CBT Sep25 | — | 16,954,400 | $527.51K | 0.03% |
| 45 | U.S. Treasury Bills | — | 500,000 | $497.40K | 0.03% |
| 46 | US ULTRA BOND CBT Sep25 | — | 1 | $303.03K | 0.02% |
| 47 | US ULTRA BOND CBT Sep25 | — | 1 | $289.95K | 0.02% |
| 48 | US ULTRA BOND CBT Sep25 | — | 1 | $256.55K | 0.02% |
| 49 | US ULTRA BOND CBT Sep25 | — | 1 | $179.71K | 0.01% |
| 50 | US ULTRA BOND CBT Sep25 | — | 1 | $154.89K | 0.01% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.